{"protocolSection": {"identificationModule": {"nctId": "NCT00160563", "orgStudyIdInfo": {"id": "A00384"}, "organization": {"fullName": "UCB Pharma", "class": "INDUSTRY"}, "briefTitle": "Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464)", "officialTitle": "The Prolongation of the EPAAC\u2122 Trial - NCT00152464 (The Early Prevention of Asthma in Atopic Children). A Multi-country, Double Blind, Placebo (PLC) Controlled, Follow-up Trial With 3 Parallel Groups (LCTZ-LCTZ, LCTZ-PLC and PLC-PLC) : Evaluation of the Long Term Efficacy and Safety of Levocetirizine (LCTZ) (5 mg/ml Oral Drops -0.125 mg/kg b.w. b.i.d.) Administered for an Additional 18 Months Period in Preventing the Onset of Asthma in Children Coming From the EPAAC Trial."}, "statusModule": {"statusVerifiedDate": "2011-05", "overallStatus": "TERMINATED", "whyStopped": "The predecessor study A00309 (NCT00152464) did not show statistical significance in time to onset of asthma between the levocetirizine and placebo groups.", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2004-06"}, "primaryCompletionDateStruct": {"date": "2006-03", "type": "ACTUAL"}, "completionDateStruct": {"date": "2006-03", "type": "ACTUAL"}, "studyFirstSubmitDate": "2005-09-08", "studyFirstSubmitQcDate": "2005-09-08", "studyFirstPostDateStruct": {"date": "2005-09-12", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2009-06-17", "resultsFirstSubmitQcDate": "2009-06-17", "resultsFirstPostDateStruct": {"date": "2009-08-04", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2015-02-12", "lastUpdatePostDateStruct": {"date": "2015-03-03", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "UCB Pharma", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "Prolongation of the EPAAC\u2122 trial - NCT00152464 (The Early Prevention of Asthma in Atopic Children).\n\n36 months study to evaluate the efficacy and safety of levocetirizine (LCTZ) in preventing the onset of asthma in young atopic children."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["Pediatry", "EPAAC", "atopic Children", "prevention of asthma", "Levocetirizine", "Xyzal"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "QUADRUPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 207, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "LCTZ-LCTZ", "type": "EXPERIMENTAL", "description": "Levocetirizine after having been randomized to Levocetirizine in the preceding A00309 trial - NCT00152464 (LCTZ-LCTZ)", "interventionNames": ["Drug: LEVOCETIRIZINE"]}, {"label": "LCTZ-PLC", "type": "PLACEBO_COMPARATOR", "description": "Placebo after having been randomized to Levocetirizine in the preceding A00309 trial - NCT00152464 (LCTZ - PLC)", "interventionNames": ["Other: Placebo"]}, {"label": "PLC-PLC", "type": "PLACEBO_COMPARATOR", "description": "Placebo after having been randomized to Placebo in the preceding A00309 trial - NCT00152464 (PLC-PLC)", "interventionNames": ["Other: Placebo"]}], "interventions": [{"type": "DRUG", "name": "LEVOCETIRIZINE", "description": "5mg/mL oral drops, 0.125 mg/kg body weight, bid for 18 months", "armGroupLabels": ["LCTZ-LCTZ"], "otherNames": ["Xyzal\u00ae"]}, {"type": "OTHER", "name": "Placebo", "description": "Oral drops, bid for 18 months", "armGroupLabels": ["LCTZ-PLC", "PLC-PLC"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Time to Onset of Asthma", "timeFrame": "36 months (from the randomization visit to the preceding A00309 - NCT00152464 trial onwards.)"}], "secondaryOutcomes": [{"measure": "Time to Onset of Asthma in the Subset of Subjects Still Asthma Free After First 18 Months.", "timeFrame": "18 months (from the end of the preceding A00309 - NCT00152464 trial onwards.)"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\nInclusion criteria which must be verified at the end of first 18-months treatment (Visit 9)\n\n* Having completed the previous 18-month treatment period of the EPAAC trial - NCT00152464\n\nExclusion Criteria:\n\n* None", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "30 Months", "maximumAge": "42 Months", "stdAges": ["CHILD"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Isabelle Campine, MD", "affiliation": "UCB Pharma", "role": "STUDY_DIRECTOR"}], "locations": [{"city": "North Adelaide", "country": "Australia", "geoPoint": {"lat": -34.90733, "lon": 138.59141}}, {"city": "Parkville (North Melbourne)", "country": "Australia"}, {"city": "Bruxelles", "country": "Belgium", "geoPoint": {"lat": 50.85045, "lon": 4.34878}}, {"city": "Brno", "country": "Czech Republic", "geoPoint": {"lat": 49.19522, "lon": 16.60796}}, {"city": "Hradec Kralove", "country": "Czech Republic", "geoPoint": {"lat": 50.20923, "lon": 15.83277}}, {"city": "Olomouc", "country": "Czech Republic", "geoPoint": {"lat": 49.59552, "lon": 17.25175}}, {"city": "Ostrava 9", "country": "Czech Republic", "geoPoint": {"lat": 49.83465, "lon": 18.28204}}, {"city": "Plezen-Lochotin", "country": "Czech Republic"}, {"city": "Praha 5", "country": "Czech Republic", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"city": "Praha 8", "country": "Czech Republic", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"city": "Martigues", "country": "France", "geoPoint": {"lat": 43.40735, "lon": 5.05526}}, {"city": "Saint-Etienne Cedex 2", "country": "France", "geoPoint": {"lat": 45.43389, "lon": 4.39}}, {"city": "Tarbes Cedex", "country": "France", "geoPoint": {"lat": 43.23333, "lon": 0.08333}}, {"city": "Toulouse Cedex 3", "country": "France", "geoPoint": {"lat": 43.60426, "lon": 1.44367}}, {"city": "Bayreuth", "country": "Germany", "geoPoint": {"lat": 49.94782, "lon": 11.57893}}, {"city": "Berlin", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"city": "Bielefeld", "country": "Germany", "geoPoint": {"lat": 52.03333, "lon": 8.53333}}, {"city": "Bochum", "country": "Germany", "geoPoint": {"lat": 51.48165, "lon": 7.21648}}, {"city": "Erlangen", "country": "Germany", "geoPoint": {"lat": 49.59099, "lon": 11.00783}}, {"city": "Koln", "country": "Germany", "geoPoint": {"lat": 50.93333, "lon": 6.95}}, {"city": "Munchen", "country": "Germany", "geoPoint": {"lat": 48.13743, "lon": 11.57549}}, {"city": "Wesel", "country": "Germany", "geoPoint": {"lat": 51.6669, "lon": 6.62037}}, {"city": "Ancona", "country": "Italy", "geoPoint": {"lat": 43.5942, "lon": 13.50337}}, {"city": "Bari", "country": "Italy", "geoPoint": {"lat": 41.11148, "lon": 16.8554}}, {"city": "Bologna", "country": "Italy", "geoPoint": {"lat": 44.49381, "lon": 11.33875}}, {"city": "Messina", "country": "Italy", "geoPoint": {"lat": 38.19394, "lon": 15.55256}}, {"city": "Milano", "country": "Italy", "geoPoint": {"lat": 45.46427, "lon": 9.18951}}, {"city": "Napoli", "country": "Italy", "geoPoint": {"lat": 40.85216, "lon": 14.26811}}, {"city": "Pavia", "country": "Italy", "geoPoint": {"lat": 45.19205, "lon": 9.15917}}, {"city": "Roma", "country": "Italy", "geoPoint": {"lat": 41.89193, "lon": 12.51133}}, {"city": "Bialystock", "country": "Poland"}, {"city": "Gdansk", "country": "Poland", "geoPoint": {"lat": 54.35205, "lon": 18.64637}}, {"city": "Karpacz", "country": "Poland", "geoPoint": {"lat": 50.77669, "lon": 15.75594}}, {"city": "Lodz", "country": "Poland", "geoPoint": {"lat": 51.75, "lon": 19.46667}}, {"city": "Lublin", "country": "Poland", "geoPoint": {"lat": 51.25, "lon": 22.56667}}, {"city": "Rabka Zdroj", "country": "Poland", "geoPoint": {"lat": 49.60889, "lon": 19.96654}}, {"city": "Warszawa", "country": "Poland", "geoPoint": {"lat": 52.22977, "lon": 21.01178}}, {"city": "Wroclaw", "country": "Poland", "geoPoint": {"lat": 51.1, "lon": 17.03333}}, {"city": "Bellville", "country": "South Africa", "geoPoint": {"lat": -33.90022, "lon": 18.62847}}, {"city": "Clarement", "country": "South Africa"}, {"city": "Durban", "country": "South Africa", "geoPoint": {"lat": -29.8579, "lon": 31.0292}}, {"city": "Mowbray", "country": "South Africa", "geoPoint": {"lat": -33.94802, "lon": 18.47333}}, {"city": "Pietermaritzburg", "country": "South Africa", "geoPoint": {"lat": -29.61679, "lon": 30.39278}}, {"city": "Sydenham", "country": "South Africa"}, {"city": "West Honeydew", "country": "South Africa"}, {"city": "Westville", "country": "South Africa", "geoPoint": {"lat": -29.82554, "lon": 30.937}}, {"city": "Wynberg", "country": "South Africa"}, {"city": "Barcelona", "country": "Spain", "geoPoint": {"lat": 41.38879, "lon": 2.15899}}, {"city": "Espluques de Llobreqat", "country": "Spain"}, {"city": "Dorchester", "country": "United Kingdom", "geoPoint": {"lat": 50.71667, "lon": -2.43333}}, {"city": "Enfield", "country": "United Kingdom"}, {"city": "Southampton", "country": "United Kingdom", "geoPoint": {"lat": 50.90395, "lon": -1.40428}}]}, "referencesModule": {"seeAlsoLinks": [{"label": "For FDA Safety Alerts and Recalls refer to", "url": "http://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "In total, 207 subjects from study A00309 - NCT00152464 entered this prolongation study. Participants Flow and Baseline Characteristics sections show patients as randomized. One patient (016/1709) received LCTZ instead of PLC in the PLC-PLC arm erroneously and is described separately in the Adverse Event section.", "recruitmentDetails": "This study is a 18-month prolongation study to study A00309 (EPAAC study - NCT00152464) and was prematurely terminated due to the fact that the primary endpoint in study A00309 - NCT00152464 was not met.", "groups": [{"id": "FG000", "title": "LCTZ-LCTZ", "description": "Levocetirizine after having been randomized to Levocetirizine in the preceding A00309 trial (LCTZ-LCTZ)"}, {"id": "FG001", "title": "LCTZ-PLC", "description": "Placebo after having been randomized to Levocetirizine in the preceding A00309 trial (LCTZ - PLC)"}, {"id": "FG002", "title": "PLC-PLC", "description": "Placebo after having been randomized to Placebo in the preceding A00309 trial (PLC-PLC)"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "59"}, {"groupId": "FG001", "numSubjects": "47"}, {"groupId": "FG002", "numSubjects": "101"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "8"}, {"groupId": "FG001", "numSubjects": "2"}, {"groupId": "FG002", "numSubjects": "11"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "51"}, {"groupId": "FG001", "numSubjects": "45"}, {"groupId": "FG002", "numSubjects": "90"}]}], "dropWithdraws": [{"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "1"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "2"}]}, {"type": "Protocol Violation", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "3"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "2"}, {"groupId": "FG002", "numSubjects": "3"}]}, {"type": "Other (listed in the study report)", "reasons": [{"groupId": "FG000", "numSubjects": "48"}, {"groupId": "FG001", "numSubjects": "40"}, {"groupId": "FG002", "numSubjects": "81"}]}, {"type": "Missing reason", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "LCTZ-LCTZ", "description": "Levocetirizine after having been randomized to Levocetirizine in the preceding A00309 trial (LCTZ-LCTZ)"}, {"id": "BG001", "title": "LCTZ-PLC", "description": "Placebo after having been randomized to Levocetirizine in the preceding A00309 trial (LCTZ - PLC)"}, {"id": "BG002", "title": "PLC-PLC", "description": "Placebo after having been randomized to Placebo in the preceding A00309 trial (PLC-PLC)"}, {"id": "BG003", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "59"}, {"groupId": "BG001", "value": "47"}, {"groupId": "BG002", "value": "101"}, {"groupId": "BG003", "value": "207"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "months", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "19.6", "spread": "3.58"}, {"groupId": "BG001", "value": "18.9", "spread": "4.08"}, {"groupId": "BG002", "value": "19.2", "spread": "4.10"}, {"groupId": "BG003", "value": "19.2", "spread": "3.94"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "23"}, {"groupId": "BG001", "value": "25"}, {"groupId": "BG002", "value": "38"}, {"groupId": "BG003", "value": "86"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "36"}, {"groupId": "BG001", "value": "22"}, {"groupId": "BG002", "value": "63"}, {"groupId": "BG003", "value": "121"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "France", "categories": [{"measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "9"}, {"groupId": "BG003", "value": "14"}]}]}, {"title": "Czech Republic", "categories": [{"measurements": [{"groupId": "BG000", "value": "9"}, {"groupId": "BG001", "value": "8"}, {"groupId": "BG002", "value": "17"}, {"groupId": "BG003", "value": "34"}]}]}, {"title": "Poland", "categories": [{"measurements": [{"groupId": "BG000", "value": "11"}, {"groupId": "BG001", "value": "9"}, {"groupId": "BG002", "value": "18"}, {"groupId": "BG003", "value": "38"}]}]}, {"title": "Spain", "categories": [{"measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "2"}, {"groupId": "BG003", "value": "3"}]}]}, {"title": "Belgium", "categories": [{"measurements": [{"groupId": "BG000", "value": "3"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "1"}, {"groupId": "BG003", "value": "4"}]}]}, {"title": "Australia", "categories": [{"measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "2"}, {"groupId": "BG003", "value": "7"}]}]}, {"title": "South Africa", "categories": [{"measurements": [{"groupId": "BG000", "value": "15"}, {"groupId": "BG001", "value": "10"}, {"groupId": "BG002", "value": "22"}, {"groupId": "BG003", "value": "47"}]}]}, {"title": "Germany", "categories": [{"measurements": [{"groupId": "BG000", "value": "9"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "13"}, {"groupId": "BG003", "value": "26"}]}]}, {"title": "Italy", "categories": [{"measurements": [{"groupId": "BG000", "value": "6"}, {"groupId": "BG001", "value": "7"}, {"groupId": "BG002", "value": "13"}, {"groupId": "BG003", "value": "26"}]}]}, {"title": "United Kingdom", "categories": [{"measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "4"}, {"groupId": "BG003", "value": "8"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Time to Onset of Asthma", "populationDescription": "Analysis was not performed due to premature discontinuation of the study.", "reportingStatus": "POSTED", "timeFrame": "36 months (from the randomization visit to the preceding A00309 - NCT00152464 trial onwards.)", "groups": [{"id": "OG000", "title": "LCTZ-LCTZ", "description": "Levocetirizine after having been randomized to Levocetirizine in the preceding A00309 trial (LCTZ-LCTZ)"}, {"id": "OG001", "title": "LCTZ-PLC", "description": "Placebo after having been randomized to Levocetirizine in the preceding A00309 trial (LCTZ - PLC)"}, {"id": "OG002", "title": "PLC-PLC", "description": "Placebo after having been randomized to Placebo in the preceding A00309 trial (PLC-PLC)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}]}]}, {"type": "SECONDARY", "title": "Time to Onset of Asthma in the Subset of Subjects Still Asthma Free After First 18 Months.", "populationDescription": "Analysis was not performed due to premature discontinuation of the study.", "reportingStatus": "POSTED", "timeFrame": "18 months (from the end of the preceding A00309 - NCT00152464 trial onwards.)", "groups": [{"id": "OG000", "title": "LCTZ-LCTZ", "description": "Levocetirizine after having been randomized to Levocetirizine in the preceding A00309 trial (LCTZ-LCTZ)"}, {"id": "OG001", "title": "LCTZ-PLC", "description": "Placebo after having been randomized to Levocetirizine in the preceding A00309 trial (LCTZ - PLC)"}, {"id": "OG002", "title": "PLC-PLC", "description": "Placebo after having been randomized to Placebo in the preceding A00309 trial (PLC-PLC)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "eventGroups": [{"id": "EG000", "title": "LCTZ-LCTZ", "description": "Levocetirizine after having been randomized to Levocetirizine in the preceding A00309 trial (LCTZ-LCTZ)", "seriousNumAffected": 5, "seriousNumAtRisk": 59, "otherNumAffected": 48, "otherNumAtRisk": 59}, {"id": "EG001", "title": "LCTZ-PLC", "description": "Placebo after having been randomized to Levocetirizine in the preceding A00309 trial (LCTZ - PLC)", "seriousNumAffected": 3, "seriousNumAtRisk": 47, "otherNumAffected": 36, "otherNumAtRisk": 47}, {"id": "EG002", "title": "PLC-PLC", "description": "Placebo after having been randomized to Placebo in the preceding A00309 trial (PLC-PLC)", "seriousNumAffected": 3, "seriousNumAtRisk": 100, "otherNumAffected": 71, "otherNumAtRisk": 100}, {"id": "EG003", "title": "PLC-LCTZ", "description": "Levocetirizine after having been randomized to Placebo in the preceding A00309 trial (PLC-LCTZ) erroneously (Patient 016/1709)", "seriousNumAffected": 0, "seriousNumAtRisk": 1, "otherNumAffected": 1, "otherNumAtRisk": 1}], "seriousEvents": [{"term": "Inguinal hernia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Vomiting", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Bronchopneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Gastroenteritis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Femur fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Atelectasis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Dyspnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Wheezing", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 2, "numAffected": 1, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Dermatitis atopic", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Urticaria", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}], "otherEvents": [{"term": "Conjunctivitis", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 3, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 8, "numAffected": 5, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 7, "numAffected": 5, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 5, "numAffected": 5, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Vomiting", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 5, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 6, "numAffected": 4, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 6, "numAffected": 5, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Pyrexia", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 13, "numAffected": 10, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 9, "numAffected": 7, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 20, "numAffected": 13, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Acute tonsillitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 5, "numAffected": 4, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 1}]}, {"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 11, "numAffected": 9, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 10, "numAffected": 6, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 26, "numAffected": 16, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Bronchitis acute", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 3, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 4, "numAffected": 3, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 6, "numAffected": 5, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Ear infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 5, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 3, "numAffected": 2, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 10, "numAffected": 6, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Gastroenteritis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 8, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 11, "numAffected": 9, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Laryngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 4, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 4, "numAffected": 3, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Nasopharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 15, "numAffected": 10, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 21, "numAffected": 11, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 46, "numAffected": 17, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Otitis media", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 5, "numAffected": 4, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 15, "numAffected": 9, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Otitis media acute", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 2, "numAffected": 1, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 6, "numAffected": 5, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Pharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 8, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 27, "numAffected": 10, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 19, "numAffected": 12, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Rhinitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 32, "numAffected": 15, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 4, "numAffected": 3, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 32, "numAffected": 12, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 1}]}, {"term": "Scarlet fever", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 3, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Tonsillitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 2, "numAffected": 1, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 11, "numAffected": 10, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 46, "numAffected": 17, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 30, "numAffected": 10, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 48, "numAffected": 20, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Varicella", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 7, "numAffected": 7, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}, {"term": "Viral infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 8.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 59}, {"groupId": "EG001", "numEvents": 6, "numAffected": 5, "numAtRisk": 47}, {"groupId": "EG002", "numEvents": 6, "numAffected": 4, "numAtRisk": 100}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 1}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "UCB has \\> 60 days but \\<= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome."}, "pointOfContact": {"title": "UCB Clinical Trial Call Center", "organization": "UCB Pharma", "phone": "+1 877 822 9493"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "removedCountries": ["Austria"]}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M7071", "name": "Dermatitis, Atopic", "relevance": "LOW"}, {"id": "M7067", "name": "Dermatitis", "relevance": "LOW"}, {"id": "M7655", "name": "Eczema", "relevance": "LOW"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC16", "name": "Diseases and Abnormalities at or Before Birth"}, {"abbrev": "BC17", "name": "Skin and Connective Tissue Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "C000472067", "term": "Levocetirizine"}], "ancestors": [{"id": "D000039563", "term": "Histamine H1 Antagonists, Non-Sedating"}, {"id": "D000006634", "term": "Histamine H1 Antagonists"}, {"id": "D000006633", "term": "Histamine Antagonists"}, {"id": "D000018494", "term": "Histamine Agents"}, {"id": "D000018377", "term": "Neurotransmitter Agents"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}], "browseLeaves": [{"id": "M263786", "name": "Levocetirizine", "asFound": "Bright", "relevance": "HIGH"}, {"id": "M9708", "name": "Histamine", "relevance": "LOW"}, {"id": "M9710", "name": "Histamine H1 Antagonists", "relevance": "LOW"}, {"id": "M212144", "name": "Histamine phosphate", "relevance": "LOW"}, {"id": "M24826", "name": "Histamine H1 Antagonists, Non-Sedating", "relevance": "LOW"}, {"id": "M9709", "name": "Histamine Antagonists", "relevance": "LOW"}, {"id": "M20504", "name": "Neurotransmitter Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}